Results 171 to 180 of about 111,297 (312)
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT This case describes a female infant with RAF1‐related Noonan syndrome who developed severe hypertrophic obstructive cardiomyopathy, pulmonary hypertension, and cardiorespiratory failure that responded to trametinib treatment but ultimately progressed to death following dose tapering and discontinuation of therapy. To the best of our knowledge,
C. Noah Nilsson +8 more
wiley +1 more source
The Turkish Journal of Pediatrics, 2010 Despite the relatively recent introduction of propranolol in the treatment of infantile hemangiomas, there can be little doubt of its efficacy. With regard to safety issues, there are no prior data for very low weight infants.
Ayşe Erbay +10 more
doaj
Propranolol for Off-label Treatment of Patients With Melanoma: Results From a Cohort Study
JAMA Oncology, 2017 V. de Giorgi +7 more
semanticscholar +1 more source
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Idiopathic granulomatous mastitis (IGM) is a rare inflammatory breast disorder, primarily attributed to immunological dysregulation, hormonal imbalances, or fertility‐related conditions. We report a 26‐year‐old female with autism spectrum disorder (ASD) under long‐term multidrug psychotropic treatment who developed IGM.
Esmat Davoudi‐Monfared +5 more
wiley +1 more source
, 2018 Propranolol (PRO) is a p-blocker used in the treatment of heart disease. Recently, it has become a kind of organic pollutions due to its wide-spread use.
Bao, Jingjing +7 more
core
Beta Blocker Toxicity at Therapeutic Doses: A Look Into Carvedilol Use in the Elderly
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Beta‐blocker toxicity does not occur only in overdose situations. In vulnerable populations such as children and the elderly, therapeutic doses may produce cumulative toxic effects similar to those seen in acute overdose. These patients require monitoring that extends beyond basic laboratory investigations to preempt cumulative toxicity.
Samuel Amo‐Tachie
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Extrahepatic portal venous obstruction (EHPVO) is a leading cause of prehepatic portal hypertension in children, particularly in developing countries. While upper gastrointestinal bleeding is the most common presentation, EHPVO may rarely manifest predominantly with hematological abnormalities due to hypersplenism, posing a diagnostic ...
Swekchha Adhikari +6 more
wiley +1 more source
Propranolol in the Surgical Management of Thyrotoxicosis
, 2008 The purpose of this present study is to observe the use of propranolol as the preoperative medication for thyrotoxic patients. Twenty patients in Group 1 were given only propranolol 60-160 mg/day orally for 3 to 21 days.
LIAW, KOUNG-YI;CHANG, CHIEH-YAO;CHANG, CHING-CHUNG;CHEN, FANG-WU +1 more
core
Food Science &Nutrition, Volume 14, Issue 6, June 2026.Achillea millefolium Linn., commonly known as yarrow, is an extraordinary medicinal plant. A. millefolium has broad therapeutic potential due to its phytochemistry and essential oil composition. It possesses pharmacological properties, including antidiabetic, antioxidant, anti‐inflammatory, liver‐protective, antimicrobial, and gastroprotective effects,
Tooba Majeed +14 more
wiley +1 more source
Cyclosporine의 체내동태에 미치는 propranolol HC1의 영향
, 1998 The effects of propranolol HCl on pharmacokinetic parameters of cyclosporine were investigated in rats. Cyclosporine, which is a lipophilic cyclic polypeptide, has been used as first-line immunosuppressive agent in transplantation of kidney, liver ...
이용화
core